Abstract:Objectives: Early detection of cancer and its curable precursors remains the best way to ensure patient survival and quality of life. Despite significant advances in treatment, oral cancer still results in 10,000 U.S. deaths annually, mainly due to the late detection of most oral lesions. Specific aim was to use a combination of non-invasive optical in vivo technologies to test a multi-modality approach to non-invasive diagnostics of oral premalignancy and malignancy. Methods: In the hamster cheek pouch model (120 hamsters), in vivo optical coherence tomography (OCT) and optical Doppler tomography (ODT) mapped epithelial, subepithelial and vascular change throughout carcinogenesis in specific, marked sites. In vivo multi-wavelength multi-photon (MPM) and second harmonic generated (SHG) fluorescence techniques provided parallel data on surface and subsurface tissue structure, specifically collagen presence and structure, cellular presence, and vasculature. Images were diagnosed by 2 blinded, pre-standardized investigators using a standardized scale from 0-6 for all modalities. After sacrifice, histopathological sections were prepared and pathology evaluated on a scale of 0-6. ANOVA techniques compared imaging diagnostics with histopathology. 95% confidence limits of the sensitivity and specificity were established for the diagnostic capability of OCT/ODT+ MPM/SHG using ROC curves and kappa statistics. Results: Imaging data were reproducibly obtained with good accuracy. Carcinogenesis-related structural and vascular changes were clearly visible to tissue depths of 2mm. Sensitivity (OCT/ODT alone: 71-88%; OCT+MPM/SHG: 79-91%) and specificity (OCT alone: 62-83%;OCT+MPM/SHG: 67-90%) compared well with conventional techniques. Conclusions: OCT/ODT and MPM/SHG are promising non-invasive in vivo diagnostic modalities for oral dysplasia and malignancy. Supported by CRFA 30003, CCRP 00-01391V-20235, NIH (LAMMP) RR01192, DOE DE903-91ER 61227, NIH EB-00293 CA91717, NSF BES-86924, AFOSR FA 9550-04-1-0101.

A roadmap for the clinical implementation of optical-imaging biomarkers

Imaging biomarker roadmap for cancer studies

Optical imaging for screening and early cancer diagnosis in low-resource settings

Oculomics: A Crusade Against the Four Horsemen of Chronic Disease

Clinically Available Optical Imaging Technologies in Endoscopic Lesion Detection: Current Status and Future Perspective

Imaging Biomarkers of Oral Dysplasia and Carcinoma Measured with In Vivo Endoscopic Optical Coherence Tomography

Optical Biopsy of Melanoma and Basal Cell Carcinoma Progression by Noncontact Photoacoustic and Optical Coherence Tomography: in Vivo Multi-Parametric Characterizing Tumor Microenvironment

Progress toward optical biopsy: bringing the microscope to the patient

Multimodal Raman Spectroscopy and Optical Coherence Tomography for Biomedical Analysis

A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption

Noninvasive imaging of oral premalignancy and malignancy

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Optical biopsy mapping for minimally invasive cancer screening.

Optical spectroscopy-based imaging techniques for the diagnosis of breast cancer: A novel approach

Optical Biosensors for Detection of Cancer Biomarkers: Current and Future Perspectives

Improving Oral Cancer Outcomes with Imaging and Artificial Intelligence

Spectroscopic sensing of cancer and cancer therapy: current status of translational research

Multimodal and multispectral diagnostic devices for oral and breast cancer screening in low resource settings

Recent Advances in Optical Imaging of Biomarkers in Vivo

Novel endoscopic optical diagnostic technologies in medical trial research: recent advancements and future prospects.